A testing algorithm for determination of HER2 status in patients with breast cancer

The HER2 gene is amplified and overexpressed in 25-30% of breast carcinomas. Assessment of HER2 status for prognosis and treatment of breast cancer patients can be performed by immunohistochemistry and/or fluorescence in situ hybridization (FISH). To develop a testing algorithm for HER2 in breast ca...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of clinical and laboratory science 2002, Vol.32 (1), p.3-11
Hauptverfasser:	NICHOLS, Dawn W, WOLFF, Daynna J, SELF, Sally, METCALF, John S, JACOBS, Donna, KNEUPER-HALL, Rayna, CATE, John C
Format:	Artikel
Sprache:	eng
Schlagworte:	Algorithms Biological and medical sciences Breast Neoplasms - genetics Breast Neoplasms - metabolism Female Gene Dosage Genes, erbB-2 Gynecology. Andrology. Obstetrics Humans Immunohistochemistry In Situ Hybridization, Fluorescence Mammary gland diseases Medical sciences Observer Variation Receptor, ErbB-2 - metabolism Single-Blind Method Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!